Logo image of 1SUS.MI

SENTINELONE INC -CLASS A (1SUS.MI) Stock Fundamental Analysis

Europe - BIT:1SUS - US81730H1095 - Common Stock

15.05 EUR
+0.8 (+5.61%)
Last: 10/30/2025, 7:00:00 PM
Fundamental Rating

4

1SUS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 107 industry peers in the Software industry. No worries on liquidiy or solvency for 1SUS as it has an excellent financial health rating, but there are worries on the profitability. 1SUS shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year 1SUS was profitable.
1SUS had a positive operating cash flow in the past year.
1SUS had negative earnings in each of the past 5 years.
1SUS had negative operating cash flow in 4 of the past 5 years.
1SUS.MI Yearly Net Income VS EBIT VS OCF VS FCF1SUS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M

1.2 Ratios

With a Return On Assets value of -18.27%, 1SUS is not doing good in the industry: 83.50% of the companies in the same industry are doing better.
With a Return On Equity value of -28.48%, 1SUS is not doing good in the industry: 75.73% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -18.27%
ROE -28.48%
ROIC N/A
ROA(3y)-14.45%
ROA(5y)-15.84%
ROE(3y)-20.46%
ROE(5y)-23.39%
ROIC(3y)N/A
ROIC(5y)N/A
1SUS.MI Yearly ROA, ROE, ROIC1SUS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 100 -100 200 300

1.3 Margins

1SUS's Gross Margin of 74.95% is in line compared to the rest of the industry. 1SUS outperforms 56.31% of its industry peers.
1SUS's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for 1SUS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.32%
GM growth 5Y4.22%
1SUS.MI Yearly Profit, Operating, Gross Margins1SUS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

7

2. Health

2.1 Basic Checks

1SUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
1SUS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for 1SUS has been increased compared to 5 years ago.
There is no outstanding debt for 1SUS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
1SUS.MI Yearly Shares Outstanding1SUS.MI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 100M 200M 300M
1SUS.MI Yearly Total Debt VS Total Assets1SUS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

1SUS has an Altman-Z score of 3.19. This indicates that 1SUS is financially healthy and has little risk of bankruptcy at the moment.
1SUS has a Altman-Z score (3.19) which is comparable to the rest of the industry.
There is no outstanding debt for 1SUS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.19
ROIC/WACCN/A
WACC10.99%
1SUS.MI Yearly LT Debt VS Equity VS FCF1SUS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

1SUS has a Current Ratio of 1.83. This is a normal value and indicates that 1SUS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.83, 1SUS is in the better half of the industry, outperforming 67.96% of the companies in the same industry.
A Quick Ratio of 1.83 indicates that 1SUS should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.83, 1SUS is in the better half of the industry, outperforming 70.87% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 1.83
1SUS.MI Yearly Current Assets VS Current Liabilites1SUS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

8

3. Growth

3.1 Past

1SUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 350.00%, which is quite impressive.
The Revenue has grown by 25.39% in the past year. This is a very strong growth!
1SUS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 77.59% yearly.
EPS 1Y (TTM)350%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
Revenue 1Y (TTM)25.39%
Revenue growth 3Y58.89%
Revenue growth 5Y77.59%
Sales Q2Q%21.74%

3.2 Future

Based on estimates for the next years, 1SUS will show a very strong growth in Earnings Per Share. The EPS will grow by 84.57% on average per year.
Based on estimates for the next years, 1SUS will show a very strong growth in Revenue. The Revenue will grow by 22.16% on average per year.
EPS Next Y279.66%
EPS Next 2Y158.17%
EPS Next 3Y112.01%
EPS Next 5Y84.57%
Revenue Next Year22.42%
Revenue Next 2Y21.63%
Revenue Next 3Y20.4%
Revenue Next 5Y22.16%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
1SUS.MI Yearly Revenue VS Estimates1SUS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B
1SUS.MI Yearly EPS VS Estimates1SUS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 1 2

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 167.22, the valuation of 1SUS can be described as expensive.
1SUS's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of 1SUS to the average of the S&P500 Index (25.89), we can say 1SUS is valued expensively.
1SUS is valuated quite expensively with a Price/Forward Earnings ratio of 52.21.
The rest of the industry has a similar Price/Forward Earnings ratio as 1SUS.
1SUS is valuated expensively when we compare the Price/Forward Earnings ratio to 34.59, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 167.22
Fwd PE 52.21
1SUS.MI Price Earnings VS Forward Price Earnings1SUS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1SUS is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 351.28
EV/EBITDA N/A
1SUS.MI Per share data1SUS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

1SUS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as 1SUS's earnings are expected to grow with 112.00% in the coming years.
PEG (NY)0.6
PEG (5Y)N/A
EPS Next 2Y158.17%
EPS Next 3Y112.01%

0

5. Dividend

5.1 Amount

1SUS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SENTINELONE INC -CLASS A

BIT:1SUS (10/30/2025, 7:00:00 PM)

15.05

+0.8 (+5.61%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-28 2025-08-28/amc
Earnings (Next)12-02 2025-12-02/amc
Inst Owners82.27%
Inst Owner ChangeN/A
Ins Owners0.53%
Ins Owner ChangeN/A
Market Cap5.04B
Revenue(TTM)907.38M
Net Income(TTM)-429.36M
Analysts78.6
Price Target21.18 (40.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.04%
Min EPS beat(2)23.01%
Max EPS beat(2)37.07%
EPS beat(4)3
Avg EPS beat(4)33.72%
Min EPS beat(4)-100%
Max EPS beat(4)174.81%
EPS beat(8)7
Avg EPS beat(8)85.06%
EPS beat(12)11
Avg EPS beat(12)65.32%
EPS beat(16)15
Avg EPS beat(16)53.02%
Revenue beat(2)0
Avg Revenue beat(2)-1.81%
Min Revenue beat(2)-1.95%
Max Revenue beat(2)-1.67%
Revenue beat(4)0
Avg Revenue beat(4)-1.42%
Min Revenue beat(4)-1.95%
Max Revenue beat(4)-0.52%
Revenue beat(8)3
Avg Revenue beat(8)-0.28%
Revenue beat(12)5
Avg Revenue beat(12)-0.13%
Revenue beat(16)9
Avg Revenue beat(16)1.44%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0.17%
EPS NQ rev (3m)-5.92%
EPS NY rev (1m)-0.57%
EPS NY rev (3m)-0.37%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)1.23%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)-0.1%
Valuation
Industry RankSector Rank
PE 167.22
Fwd PE 52.21
P/S 6.43
P/FCF 351.28
P/OCF 143.44
P/B 3.87
P/tB 7.44
EV/EBITDA N/A
EPS(TTM)0.09
EY0.6%
EPS(NY)0.29
Fwd EY1.92%
FCF(TTM)0.04
FCFY0.28%
OCF(TTM)0.1
OCFY0.7%
SpS2.34
BVpS3.89
TBVpS2.02
PEG (NY)0.6
PEG (5Y)N/A
Graham Number2.81
Profitability
Industry RankSector Rank
ROA -18.27%
ROE -28.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.95%
FCFM 1.83%
ROA(3y)-14.45%
ROA(5y)-15.84%
ROE(3y)-20.46%
ROE(5y)-23.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.32%
GM growth 5Y4.22%
F-Score6
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 53.73%
Cap/Sales 2.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 1.83
Altman-Z 3.19
F-Score6
WACC10.99%
ROIC/WACCN/A
Cap/Depr(3y)58.32%
Cap/Depr(5y)105.17%
Cap/Sales(3y)3.59%
Cap/Sales(5y)4.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)350%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
EPS Next Y279.66%
EPS Next 2Y158.17%
EPS Next 3Y112.01%
EPS Next 5Y84.57%
Revenue 1Y (TTM)25.39%
Revenue growth 3Y58.89%
Revenue growth 5Y77.59%
Sales Q2Q%21.74%
Revenue Next Year22.42%
Revenue Next 2Y21.63%
Revenue Next 3Y20.4%
Revenue Next 5Y22.16%
EBIT growth 1Y-2.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year315.2%
EBIT Next 3Y92.41%
EBIT Next 5YN/A
FCF growth 1Y112.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y133.39%
OCF growth 3YN/A
OCF growth 5YN/A

SENTINELONE INC -CLASS A / 1SUS.MI FAQ

Can you provide the ChartMill fundamental rating for SENTINELONE INC -CLASS A?

ChartMill assigns a fundamental rating of 4 / 10 to 1SUS.MI.


What is the valuation status of SENTINELONE INC -CLASS A (1SUS.MI) stock?

ChartMill assigns a valuation rating of 3 / 10 to SENTINELONE INC -CLASS A (1SUS.MI). This can be considered as Overvalued.


How profitable is SENTINELONE INC -CLASS A (1SUS.MI) stock?

SENTINELONE INC -CLASS A (1SUS.MI) has a profitability rating of 1 / 10.


Can you provide the financial health for 1SUS stock?

The financial health rating of SENTINELONE INC -CLASS A (1SUS.MI) is 7 / 10.